Page 231 - Kolte Patil AR 2019-20

As at March 31, 2020
Number of Options Outstanding
Weighted average remaining life (in Years)
Number of Options Outstanding
-
-
379,000
0- 4
For the year ended March 31, 2020
265
145
58.77%
1 year from the date of vesting
2%
8.20%
Notes forming part of the Consolidated Financial Statements
The exercise period shall commence from the date of vesting of option and expire not later than 12 (Twelve) months from the vesting date of option. Options not exercised during any particular exercise period, can be carried forward to the subsequent exercise period(s), provided however that all the Options, have to be exercised within a period of 2 years from the date of the vesting period in respect of the final lot, after which any unexercised Options will lapse.
The vesting period of the above mentioned ESOS Schemes is as follows –
i. Details of activity of the ESOP schemes
Movement for the year ended March 31, 2020 and year ended March 31, 2019:
ESOP Scheme
ESOS 2014
Particulars
Number of options
Weighted average exercise price
Number of options
Weighted average exercise price
Year ended
March 31, 2020
March 31, 2020
March 31, 2019
March 31, 2019
Outstanding at the beginning of the year
379,000
142
26,500
142
Granted during the year
Forfeited during the year
Lapsed during the year
Exercised during the year
Outstanding at the end of the year
379,000
142
Exercisable at the end of the year
379,000
142
379,000
141
----
----
379,000
141
- 10,000
- 142
16,500 379,000
142 141
As at March 31, 2019
ii. Information in respect of options outstanding:
ESOP Scheme
ESOS 2014
Exercise price
Weighted average remaining life (in Years)
141 --
145 379,000 0 - 4
iii. The employee stock option cost for the Employee Stock Option Scheme 2014 has been computed by reference to the fair value of share options granted and amortized over each vesting period. For the year ended March 31, 2019 the Company has accounted for employee stock Option cost (equity settled) amounting to ` 196 Lakhs (March 31, 2019: ` 168 Lakhs).
iv. The fair value of each option is estimated on the date of grant based on the following assumptions (on weighted average basis):
Particulars
For the year ended March 31, 2019
Weighted average share price 265
Exercise price 145
Expected Volatility (%) 58.77%
Expected life
1 year from the date of vesting
Expected dividend (%) 2% Risk free interest rate (%) 8.20%
Annual Report 2019-20 | 229